Equity (Details) - Schedule of compensation expense related to our stock-based awards - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Schedule of Compensation Expense Related to our Stock Based Awards [Abstract] | ||||
| Research and Development | $ 1,120 | $ 1,327 | $ 3,171 | $ 4,275 |
| General and Administrative | 2,090 | 1,179 | 4,283 | 3,479 |
| Total | $ 3,210 | $ 2,506 | $ 7,454 | $ 7,754 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|